Cognision
Louisville
About Cognision
Neuronetrix will revolutionize the treatment of patients with neurologic disorders by providing meaningful diagnostic information to health care practitioners early in the disease process. We will do this by becoming the world’s innovator and leader in point-of-care neurological diagnostic services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $2.1M
- Last round: Series Unknown (Jul 2018)
- Website: cognision.com
- Phone: 502-561-9040
Industries & Categories
Clinical Trials, Health Care, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cognision-157823 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.